| Literature DB >> 35635051 |
Clemence Marchal1, Vassiliki A Michalopoulou2, Zhou Zou3, Volkan Cevik3, Panagiotis F Sarris2,4,5.
Abstract
Nucleotide-binding and leucine-rich repeat receptors (NLRs) are intracellular plant immune receptors that recognize pathogen effectors secreted into the plant cell. Canonical NLRs typically contain three conserved domains including a central nucleotide binding (NB-ARC) domain, C-terminal leucine-rich repeats (LRRs) and an N-terminal domain. A subfamily of plant NLRs contain additional noncanonical domain(s) that have potentially evolved from the integration of the effector targets in the canonical NLR structure. These NLRs with extra domains are thus referred to as NLRs with integrated domains (NLR-IDs). Here, we first summarize our current understanding of NLR-ID activation upon effector binding, focusing on the NLR pairs Pik-1/Pik-2, RGA4/RGA5, and RRS1/RPS4. We speculate on their potential oligomerization into resistosomes as it was recently shown for certain canonical plant NLRs. Furthermore, we discuss how our growing understanding of the mode of action of NLR-ID continuously informs engineering approaches to design new resistance specificities in the context of rapidly evolving pathogens.Entities:
Keywords: NLR; NLR engineering; NLR-ID; plant immunity
Mesh:
Substances:
Year: 2022 PMID: 35635051 PMCID: PMC9528084 DOI: 10.1042/EBC20210084
Source DB: PubMed Journal: Essays Biochem ISSN: 0071-1365 Impact factor: 7.258
A comprehensive list of all cloned and studied NLR-IDs to date, along with their executor NLR and pathogen resistance, where these are known
| NLR-ID | Type | ID code | Host species | Integrated domain | Executor NLR | ID code | Resistance | Citation |
|---|---|---|---|---|---|---|---|---|
| Adnr1 | CNL | TraesCS5A02G344100 | ANK, WRKY | Adnr1-RGA4 (?) | Traes CS5A02G344000 |
| [ | |
| TNL | NA |
| B3, TFSIIN | NA | NA | [ | ||
| CHS3 | TNL | NP_197291 | LIM, DA1-like domain | CSA1 | NP_197290 | NA | [ | |
| DAR5 | RPW8-like | NP_201464 | LIM, DA1-like domain | NA | - | NA | [ | |
| CNL | OsJ_34782 |
| WRKY (x2) | OsJ_34781 | NA | [ | ||
| Pi1-5 | CNL | AEB00617 | AAA | NA | - |
| [ | |
| Pi5-3 | CNL | Os09g15850 | Apoptotic protease-activating factors, helical domain | Pi5-1 | Os09g15840 | NA | [ | |
| Pi7-J-1 | CNL | ASM94220 | AAA | Pish-J | KY225901.1 |
| [ | |
| Pia-2 (RGA5) | CNL | AB604627 | HMA-like | Pia-1 (RGA4) | AB604622.1 |
| [ | |
| Pii-2 | CNL | QDZ58247 |
| NOI | Pii-1 | BAN59294 |
| [ |
| Pik-1 | CNL | ADZ48537 |
| AAA, HMA-like (Uniprot) | Pik-2 | P0DO07.1 |
| [ |
| Pike-1 | CNL | NA | CtNL | Pike-2 | NA |
| [ | |
| Pik-h1 | CNL | AET36549 |
| AAA | Pik-h2 | AET36550 |
| [ |
| Pik-m1 | CNL | AB462324 | HMA-like (Uniprot) | Pik-m2 | D5L9H7 |
| [ | |
| Pik-p1 | CNL | ADV58352 |
| AAA | Pik-p2 | ADV58351 |
| [ |
| Pik-s1 | CNL | AET36547 |
| HMA-like | Pik-s2 | AET36547 |
| [ |
| PiPR1 | CNL | XM_015780628 | ZnF_BED | NA | - |
| [ | |
| Pi-ta | CNL | ACX94088 |
| Thioredoxin | NA | - |
| [ |
| RGA2a | CNL | AGQ17376 |
| EXO70 | RGA1e | AGQ17384 | - | [ |
| RGH2 | CNL | NA | EXO70 | RGH3 | NA | [ | ||
| RLM3_Col | TNL | NM_001341182 | BRX (3x) | NA | - |
| [ | |
| RPG1 | CNL | Q8L3P8 | Pseudokinase domain (pK1), active kinase domain (pK2) | NA | - | [ | ||
| RPG5 | CNL | ACH69774 | Serine/Threonine protein kinase | RGA1,RPG4 (Adf2) | ACH69773,ACH69772 | [ | ||
| Rph15 | CNL | KAE8770059 | ZnF_BED | NA | - |
| [ | |
| Rpp1-R1 | ONL | PRGDB240989 (Glyma.18G280300) |
| ULP1 protease | NA | - |
| [ |
| Rpp1-R3 | ONL | PRGDB236486 (Glyma.18G281500) |
| ULP1 protease | NA | - |
| [ |
| Rpp1-R4 | ONL | PRGDB236494 (Glyma.18G281600) |
| ULP1 protease | NA | - |
| [ |
| Rpp1-R5 | ONL | PRGDB236455 (Glyma.18G281700) |
| ULP1 protease | NA | - |
| [ |
| RPP2A | TNL | NP_193685 | AAA (2x) | RPP2B | NP_001328446 |
| [ | |
| RRS1B | TNL | NM_180802 | WRKY | RPS4B | NP_001330960 |
| [ | |
| RRS1-R | TNL | HQ170631 | WRKY | RPS4 | NP_199338 | [ | ||
| RRS1-S | TNL | NM_123894 | WRKY | RPS4 | NP_199338 |
| [ | |
| RRS1-Ws | TNL | AB470471.1 | WRKY | RPS4-Ws | AB470473.1 | [ | ||
| SLH1 | TNL | BAD38678 | WRKY | RPS4 | NP_199338 | [ | ||
| Ta4ANPR1 | ONL | NA | HTH (x2), BTB, ANK (x2), NPR1_like_C | Ta4ANPR1-RGA4 | NA | [ | ||
| Ta7ANPR1 (RGA5) | ONL | NA | HTH (x2), BTB, ANK (x2), NPR1_like_C | Ta7ANPR1-RGA4 | NA | [ | ||
| Ta7DNPR1 | ONL | NA | HTH (x2), BTB, ANK (x2), NPR1_like_C | Ta7DNPR1-RGA4 | NA | [ | ||
| TRIDC5AG050380 | CNL | TRIDC5AG050380 |
| ANK, WRKY | NA | - | [ | |
| Tsn1 | CNL | ADH59425 | Pkinase | NA | - | [ | ||
| WRKY19 | TNL | NM_001125496 | PAH, WRKY (2x), MAPK | DSC1 | NP_192938 |
| [ | |
| Xa1 | CNL | AB002266 | ZnF_BED | NA | - | [ | ||
| Xo1 | CNL | NA | ZnF_BED | NA | - |
| [ | |
| Yr5 | CNL | QEQ12705 |
| ZnF_BED | NA | - | [ | |
| Yr7 | CNL | QEQ12704 |
| ZnF_BED | NA | - | [ | |
| YrSP | CNL | QEQ12706 |
| ZnF_BED | NA | - | [ | |
| YrU1 | CNL | QIM55694 |
| ANK, WRKY | NA | - | [ |
Most of the NLR-IDs presented in this list have been attached from RefPlantNLR [82].
Stands for ‘Other’-NL. For NLRs without a CC or TIR domain but a noncanonical domain integrated at their N-terminus (based on RefplantNLR nomenclature [82]).
Figure 1NLR-ID/NLR pair activation model
Pathogens such as bacteria, oomycetes, fungi, nematodes, or insects secrete effectors into the plant cytoplasm. The interaction of the effectors with the ID of the sensor NLR, either directly or indirectly, leads to the activation of the sensor and the executor NLRs in the cytoplasm or nucleus. We propose that the activation of the NLR pairs is accompanied with oligomerization of either the executor only, or of the sensor-executor heterodimers or of the sensor-executor in a NLRC4/NAIP5-like complex. The NLR oligomers may vary depending on the nature of the NLR pair. Some NLR pairs may also self-associate in resting stage before their activation by an effector (e.g., Pik-1/Pik-2). Created in BioRender.com.
Examples of NLR-ID engineering with corresponding targets and outcomes
| System | Cognate effector(s) | New target(s) | Methods | Gain of binding | HR in | Resistance in stable lines |
|---|---|---|---|---|---|---|
| Pikp-1/Pikp-2 | AVR-PikD | AVR-PikD,E,A,C | Structure-guided mutagenesis | Y | Y (not for AVR-PikC) | Not tested |
| RGA5/RGA4 | AVR1-CO39, AVR-Pia | AVR-PikD | Structure-guided mutagenesis | Y | Y | N |
| RGA5/RGA4 | AVR1-CO39, AVR-Pia | AVR-Pib | Structure-guided mutagenesis | Y | Y | Y |
| RRS1-R/RPS4 | PopP2, AvrRps4 | SAP05 | Domain shuffling | Y | Y | N |
| Pikm-1/Pikm-2 | AVR-PikD,E,A | GFP, mCherry | Domain shuffling | Not tested | Y | Not tested |
Figure 2Pipeline to engineer new resistance specificities in NLR-IDs
The two main avenues to engineer IDs in NLRs are structure and/or protein–protein interaction-guided mutagenesis or domain swaps. Once new binding affinity is confirmed, the next step is to express engineered sensor, executor, and newly recognized effector in a heterologous system for high-throughput screening. Providing cell death was observed in the presence of the effector, the system can be transferred into crops to test for resistance against pathogen(s), expressing the newly recognized effector. Created in BioRender.com.